Experienced in Aphthous Stomatitis

Merav Lidar

Tel Litwinsky, TA, IL 
Experienced in Aphthous Stomatitis
Tel Litwinsky, TA, IL 
OverviewLocationsClinical Research

Overview

Merav Lidar practices in Tel Litwinsky, Israel. Ms. Lidar is rated as an Experienced expert by MediFind in the treatment of Aphthous Stomatitis. Her top areas of expertise are Familial Mediterranean Fever, Ankylosing Vertebral Hyperostosis with Tylosis, Diffuse Idiopathic Skeletal Hyperostosis, Neurosarcoidosis, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 116 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Aphthous Stomatitis.

Gender
Female

Locations

Tel Litwinsky, TA, Israel
Other Locations
Ramat Gan, TA 52621, Israel
Tel Aviv, TA, Israel
Ramat Aviv, TA 69978, Israel
Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 2 Less Clinical Trials

116 Total Publications

Can a virtual multi-centre multi-disciplinary discussion improve the diagnosis and management of interstitial lung disease? A retrospective cohort study across multiple institutions.
Can a virtual multi-centre multi-disciplinary discussion improve the diagnosis and management of interstitial lung disease? A retrospective cohort study across multiple institutions.
Journal: BMJ open
Published: June 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lidar's expertise for a condition
ConditionClose
    View All 41 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile